The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical outcomes of estrogen receptor (ER)-negative and progesterone receptor (PgR)-positive invasive breast cancer.
Melissa Chan
No relevant relationships to disclose
Martin Chang
No relevant relationships to disclose
Rosa Gonzalez
No relevant relationships to disclose
Belinda Lategan
No relevant relationships to disclose
Elvira del Barco
No relevant relationships to disclose
Francisco Emilio Vera-Badillo
No relevant relationships to disclose
Paula Quesada
No relevant relationships to disclose
Robyn Goldstein
No relevant relationships to disclose
Ignacio Cruz
No relevant relationships to disclose
Alberto Ocana
No relevant relationships to disclose
Juan J. Cruz
No relevant relationships to disclose
Eitan Amir
No relevant relationships to disclose